Clinical trials
Phase 2 Lupus Erythematosus, Discoid trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Florida Academic Dermatology Centers | 1 |
| Immunovant Sciences GmbH | 1 |
| LEO Pharma | 1 |
| Massachusetts General Hospital | 1 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Discoid | 14 |
| Lupus Erythematosus, Cutaneous | 6 |
| Lupus Erythematosus, Systemic | 3 |
| Connective Tissue Diseases | 1 |
| Immune System Diseases | 1 |
| Skin Diseases | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.